Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0B9FW
|
|||
Drug Name |
Idarucizumab
|
|||
Synonyms |
Praxbind
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Reversal of the anticoagulant effects of dabigatran [ICD-11: N.A] | Approved | [1] | |
Company |
Boehringer Ingelheim
|
|||
ADReCS Drug ID | BADD_D01129 |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dabigatran (Dabi) | Target Info | Binder | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.